SIETES :: 92005 citas

Resultados de la búsqueda por USO TERAPÉUTICO REFINAR BÚSQUEDA

1.

Berkovic SF. Cannabinoids for epilepsy — Real data, at last. N Engl J Med 2017;376:2075-6. [Ref.ID 101596]

2.

Devinsky O, Cross JH, Laux L, Marsh E, Nabbout R, Scheffer IE, Thiele EA, Wright S, for the Cannabidiol in Dravet Syndrome Study Group. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med 2017;376:2011-20. [Ref.ID 101595]

3.

Wong J, Motulski A, Abrahamowicz M, McGill J, Eguale T, Buckeridge DL, Tamblyn R. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system. BMJ 2017;356:j603. [Ref.ID 101417]

4.

Morales DR, Guthrie B. Off-label prescribing of antidepressants. BMJ 2017;356:j849. [Ref.ID 101416]

5.

Anónimo. Brazil issues first license for sale of cannabis-based drug. DIA Daily 2017:1. [Ref.ID 101349]

6.

Anónimo. Psilocybin may reduce depression and anxiety in some cancer patients, studies suggest. DIA Daily 2016:1. [Ref.ID 100992]

7.

Anónimo. Various states approve recreational, medical marijuana use. DIA Daily 2016:7. [Ref.ID 100907]

8.

Anónimo. DEA withdrawing notice of intent to classify kratom as schedule I drug after public outcry. DIA Daily 2016:1. [Ref.ID 100807]

9.

Anónimo. Cannabis-derived drug successfully treats children with severe epilepsy in late-stage clinical trial. DIA Daily 2016:6. [Ref.ID 100761]

10.

Anónimo. Administration to remove roadblock to marijuana research. DIA Daily 2016:1. [Ref.ID 100571]

11.

Gulland A. Sixty seconds on . . . medical marijuana. BMJ 2016;354:i3962. [Ref.ID 100517]

12.

Anónimo. Cannabis and cannabinoids. Med Lett Drugs Ther 2016;58:97-8. [Ref.ID 100510]

13.

Rubin R. Senators urge expedited evaluation of medical use of cannabidiol. JAMA 2016;316:13 de julio. [Ref.ID 100491]

14.

Bradford AC, Bradford D. Medical marijuana laws reduce prescription medication use In Medicare Part D. Health Affairs 2016;37:julio. [Ref.ID 100483]

15.

Anónimo. FDA approves first dronabinol solution for oral use. FDA U.S. Food and Drug Administration 2016:2. [Ref.ID 100472]

16.

Anónimo. Experimental epilepsy drug derived from cannabis reduces frequency of seizures in late-stage clinical trial. DIA Daily 2016:2. [Ref.ID 100442]

17.

Anónimo. Company intends to seek FDA approval of marijuana-based medication. DIA Daily 2015:1. [Ref.ID 99725]

18.

Stafford N. Germany considers legalising cannabis for medical use. BMJ 2015;351:h5952. [Ref.ID 99681]

19.

Andreae MH, Carter GM, Shaparin N, Suslov K, Ellis RJ, Ware MA, Abrams DI, Prasad H, Wilsey B, Indyk D, Johnson M, Sacks HS. Inhaled cannabis for chronic neuropathic pain: an individual patient data meta-analysis. The Journal of Pain 2015;16:1221-32. [Ref.ID 99552]

20.

Ware MA, Wang T, Shapiro S, Collet J-P. Cannabis for the management of pain: assessment of safety study (COMPASS). The Journal of Pain 2015;16:1233-42. [Ref.ID 99551]